Primary Ciliary Dyskinesia Market is driven by Gene Therapy...

adicionou um novo artigo Health

2025-04-29 12:18:46 -

Primary Ciliary Dyskinesia Market is driven by Gene Therapy Advancements

The Primary Ciliary Dyskinesia (PCD) Market encompasses diagnostic assays, pharmacological interventions, and innovative gene-based treatments designed to address the structural and functional defects of motile cilia in respiratory epithelium. Products include genetic testing panels, high-resolution microscopy diagnostics, inhaled mucolytics, anti-inflammatory agents, and emerging gene-editing...

0 Comentários 0 Compartilhamentos 45 Visualizações 0 Anterior